Recently, the Ministry of Health issued Official Dispatch No. 5946/BYT-DP regarding the provisional allocation of COVID-19 vaccines through the end of 2021 to 63 provinces and cities, units, ministries, and sectors. Accordingly, in 2021, the Ministry of Health plans to allocate vaccines to achieve a coverage rate of 90% for individuals aged 18 and older, with Hanoi and Ho Chi Minh City projected to receive the highest allocation rate of 99%.
To date, six COVID-19 vaccines have been licensed for use in Viet Nam by the Ministry of Health. Each COVID-19 vaccine offers a varying degree of protective efficacy against the disease.
Below is essential information regarding several COVID-19 vaccines currently being administered in Viet Nam. This document has been compiled based on the COVID-19 Vaccination Practice Guidelines Handbooks of the National Expanded Programme on Immunization.
Moderna Vaccine
The vaccine manufactured by Moderna has been authorized for use in 64 countries and territories and has been included in the WHO Emergency Use Listing. To date, this vaccine has been deployed in 63 countries with approximately 340 million doses administered.
This vaccine has been granted conditional approval by the Ministry of Health for urgent requirements in COVID-19 prevention and control. To date, Viet Nam has received a total of 5,001,000 doses of the Moderna vaccine donated by the United States Government through the COVAX Facility, which are currently being administered in vaccination campaigns.
